These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8674026)

  • 1. Psychosocial aspects of participation in early anticancer drug trials. Report of a pilot study.
    Cox K; Avis M
    Cancer Nurs; 1996 Jun; 19(3):177-86. PubMed ID: 8674026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
    Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
    Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectations.
    Wray RJ; Stryker JE; Winer E; Demetri G; Emmons KM
    J Cancer Educ; 2007; 22(1):21-4. PubMed ID: 17570804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying components in consent information needed to support informed decision making about trial participation: An interview study with women managing cancer.
    Abhyankar P; Velikova G; Summers B; Bekker HL
    Soc Sci Med; 2016 Jul; 161():83-91. PubMed ID: 27261532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of cohort-specific consent and patient control in phase I cancer trials.
    Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
    J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informed consent in clinical trials.
    Verheggen FW; van Wijmen FC
    Health Policy; 1996 May; 36(2):131-53. PubMed ID: 10158765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric oncologists' attitudes towards involving adolescents in decision-making concerning research participation.
    de Vries MC; Wit JM; Engberts DP; Kaspers GJ; van Leeuwen E
    Pediatr Blood Cancer; 2010 Jul; 55(1):123-8. PubMed ID: 20486177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical and practical problems of early anti-cancer drug trials: a review of the literature.
    Cox K; Avis M
    Eur J Cancer Care (Engl); 1996 Jun; 5(2):90-5. PubMed ID: 8716204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of participation in a phase I, II, or III clinical trial among African American patients with cancer: what do refusers say?
    Brown RF; Cadet DL; Houlihan RH; Thomson MD; Pratt EC; Sullivan A; Siminoff LA
    J Oncol Pract; 2013 Nov; 9(6):287-93. PubMed ID: 24130251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed consent and decision-making: patients' experiences of the process of recruitment to phases I and II anti-cancer drug trials.
    Cox K
    Patient Educ Couns; 2002 Jan; 46(1):31-8. PubMed ID: 11804767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of patient participation in clinical studies requiring informed consent: why patients enter a clinical trial.
    Verheggen FW; Nieman F; Jonkers R
    Patient Educ Couns; 1998 Oct; 35(2):111-25. PubMed ID: 10026554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing cancer clinical trial management: recommendations from a qualitative study of trial participants' experiences.
    Cox K
    Psychooncology; 2000; 9(4):314-22. PubMed ID: 10960929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer patients' perceptions of factors influencing their decisions on participation in clinical drug trials: A qualitative meta-synthesis.
    Nielsen ZE; Berthelsen CB
    J Clin Nurs; 2019 Jul; 28(13-14):2443-2461. PubMed ID: 30673153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The views of patients and healthy volunteers on participation in clinical trials: an exploratory survey study.
    Chu SH; Jeong SH; Kim EJ; Park MS; Park K; Nam M; Shim JY; Yoon YR
    Contemp Clin Trials; 2012 Jul; 33(4):611-9. PubMed ID: 22405971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for a way to live to the end: decision-making process in patients considering participation in cancer phase I clinical trials.
    Kohara I; Inoue T
    Oncol Nurs Forum; 2010 Mar; 37(2):E124-32. PubMed ID: 20189911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical communication in clinical trials. Issues faced by data managers in obtaining informed consent.
    Loh WY; Butow PN; Brown RF; Boyle F
    Cancer; 2002 Dec; 95(11):2414-21. PubMed ID: 12436450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of informed consent in a cataract surgery clinical trial: why patients participate.
    Constantinou M; Jhanji V; Chiang PP; Lamoureux EL; Rees G; Vajpayee RB
    Can J Ophthalmol; 2012 Apr; 47(2):118-23. PubMed ID: 22560415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions of cancer patients and their physicians involved in phase I trials.
    Daugherty C; Ratain MJ; Grochowski E; Stocking C; Kodish E; Mick R; Siegler M
    J Clin Oncol; 1995 May; 13(5):1062-72. PubMed ID: 7738612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.